Anika Therapeutics, Inc. Deferred Income Tax Assets, Net
Anika Therapeutics, Inc. (ANIK) had Deferred Income Tax Assets, Net of $1.02 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredIncomeTaxAssetsNet · last filed 2026-07-29
- 2026-06-30: Deferred Income Tax Assets, Net $1.02M.
- 2026-03-31: Deferred Income Tax Assets, Net $1.15M.
- 2025-12-31: Deferred Income Tax Assets, Net $1.27M.
- 2025-09-30: Deferred Income Tax Assets, Net $1.25M.
| Period end | Deferred Income Tax Assets, Net |
|---|---|
| 2026-06-30 | $1.02M 10-Q · filed 2026-07-29 |
| 2026-03-31 | $1.15M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $1.27M 10-Q · filed 2026-07-29 |
| 2025-09-30 | $1.25M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $1.25M 10-Q · filed 2025-07-30 |
| 2025-03-31 | $1.19M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $1.18M 10-K · filed 2026-03-03 |
| 2024-09-30 | $1.47M 10-Q · filed 2024-11-04 |
| 2024-06-30 | $1.36M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $1.27M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $1.49M 10-K · filed 2025-03-17 |
| 2023-09-30 | $1.42M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $1.50M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $1.52M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $1.45M 10-K · filed 2024-03-15 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |